Dyne Therapeutics (NYSE:DYN – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Sunday.
Dyne Therapeutics Price Performance
Shares of NYSE:DYN opened at $13.70 on Friday. Dyne Therapeutics has a 52 week low of $4.30 and a 52 week high of $15.63. The stock has a market capitalization of $798.86 million, a P/E ratio of -4.11 and a beta of 0.23.
Dyne Therapeutics Company Profile
Want More Great Investing Ideas?
- Get a free copy of the StockNews.com research report on Dyne Therapeutics (DYN)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Dyne Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyne Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.